NCT00031980: Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer |
|
|
| Completed | 2 | 30 | US | cyclosporine | Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI) | Anemia, Leukemia, Neutropenia, Thrombocytopenia | 05/05 | 05/05 | | |
NCT00301834: Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders |
|
|
| Completed | 2 | 35 | US | alemtuzumab, busulfan, cyclosporine, fludarabine phosphate, methotrexate, methylprednisolone, allogeneic bone marrow transplantation, allogeneic hematopoietic stem cell transplantation, peripheral blood stem cell transplantation, umbilical cord blood transplantation | University of California, San Francisco, National Cancer Institute (NCI) | Congenital Amegakaryocytic Thrombocytopenia, Diamond-blackfan Anemia, Leukemia, Myelodysplastic Syndromes, Severe Congenital Neutropenia | 09/11 | 09/11 | | |
NCT00260689: Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia |
|
|
| Completed | 2 | 136 | US | Anti-thymocyte globulin (rabbit), Anti-thymocyte globulin (horse), Cyclosporine, Alemtuzumab, Campath | National Heart, Lung, and Blood Institute (NHLBI) | Immunosuppresion, Thrombocytopenia, Pancytopenia, Neutropenia | 05/16 | 05/16 | | |
